Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001680367-25-000060
Filing Date
2025-11-06
Accepted
2025-11-06 17:15:49
Documents
13
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K/A sttk-20251106.htm   iXBRL 8-K/A 28966
2 EX-99.1 sttk_3q2025earningsrelease.htm EX-99.1 85408
  Complete submission text file 0001680367-25-000060.txt   251019

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20251106.xsd EX-101.SCH 1797
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20251106_lab.xml EX-101.LAB 24306
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20251106_pre.xml EX-101.PRE 14114
15 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20251106_htm.xml XML 3218
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39593 | Film No.: 251459557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)